These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 390693)

  • 21. Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer.
    Lau GK; Lok AS; Liang RH; Lai CL; Chiu EK; Lau YL; Lam SK
    Hepatology; 1997 Jun; 25(6):1497-501. PubMed ID: 9185774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation].
    Woo SY; Cho SH; Lee SM; Koh MB; Noh CH; Kim CW; Choi JY; Yang JM; Han JY; Lee YS
    Korean J Hepatol; 2009 Jun; 15(2):131-9. PubMed ID: 19581765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B surface antigen (HBsAg) infection in a hemodialysis unit. II. Factors affecting host immune response to HBsAg.
    Sengar DP; Rashid A; McLeish WA; Harris JE; Couture RA; Sutherland M
    Can Med Assoc J; 1975 Nov; 113(10):945-8. PubMed ID: 1104126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Aoufi S; Pascasio JM; Sousa JM; Sayago M; Ferrer MT; Gómez-Delgado E; De la Cruz MD; Alamo JM; Gómez-Bravo MA; Bernardos A; Márquez JL
    Transplant Proc; 2008 Nov; 40(9):2946-8. PubMed ID: 19010155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
    Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
    Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of hepatitis B, hepatitis delta, and human immunodeficiency virus infections in Omani patients with renal diseases.
    Aghanashinikar PN; al-Dhahry SH; al-Marhuby HA; Buhl MR; Daar AS; Al-Hasani MK
    Transplant Proc; 1992 Oct; 24(5):1913-4. PubMed ID: 1412910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infections with the hepatitis B virus associated delta agent in an isolated West-African community.
    Goudsmit J; van der Waals F; Ponzetto A; Forzani B; Dobbelaar C
    J Trop Med Hyg; 1984 Dec; 87(6):257-62. PubMed ID: 6534990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence of hepatitis B e antigen for a long period after the clearance of hepatitis B surface antigen.
    Tamura I; Shimase K; Ichimura H; Kurimura O; Kaneto E; Tsuchie H; Kurimura T
    Acta Virol; 1985 Dec; 29(6):505-8. PubMed ID: 2869663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HBe-Antigen in the course and prognosis of hepatitis B infection: a prospective study.
    Schulman AN; Fagen ND; Brezina M; Silver H; Nitzze A; Morton D; Gitnick GL
    Gastroenterology; 1980 Feb; 78(2):253-8. PubMed ID: 7350048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of hepatitis B virus DNA in peripheral blood mononuclear cells from patients with various hepatopathies using in situ hybridization].
    Suñén E; Fernández de Aranguiz A; De Las Heras B; Gorriño MT; Sarriá L; Malavé C; Campelo C; Cisterna R
    An Med Interna; 1991 Aug; 8(8):372-6. PubMed ID: 1768745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
    Gessoni G; Manoni F
    Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infection with the delta agent in chronic HBsAg carriers.
    Smedile A; Dentico P; Zanetti A; Sagnelli E; Nordenfelt E; Actis GC; Rizzetto M
    Gastroenterology; 1981 Dec; 81(6):992-7. PubMed ID: 7286594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS).
    Ogutu EO; Amayo EO; Okoth F; Lule GN
    East Afr Med J; 1990 May; 67(5):355-8. PubMed ID: 2390958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of graft survival with host response to hepatitis B infection in patients with kidney transplants.
    London WT; Drew JS; Blumberg BS; Grossman RA; Lyons PJ
    N Engl J Med; 1977 Feb; 296(5):241-4. PubMed ID: 318732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hepatitis b infection in renal transplant recipients (author's transl)].
    Schmidt P; Zazgornik J; Pesendorfer FX; Kopsa H; Pils P; Wewalka F; Deutsch E
    Wien Klin Wochenschr; 1978 Mar; 90(5):173-6. PubMed ID: 343398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Retrospective study of 149 cases of hepatitis B virus infections. Study of markers and of evolution].
    Lasserre-Baum M; Frei PC
    Schweiz Med Wochenschr; 1979 Dec; 109(46):1826-7. PubMed ID: 229549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concomitant hepatitis B surface antigen and antibody in thirteen patients.
    Foutch PG; Carey WD; Tabor E; Cianflocco AJ; Nakamoto S; Smallwood LA; Gerety RJ
    Ann Intern Med; 1983 Oct; 99(4):460-3. PubMed ID: 6625377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deficiency of antibody formation to HBsAg in the pathogenesis of chronic hepatitis and cirrhosis?
    Schlicht I; Gadow J; Ortmans H; Jorno L; Gentz HD; Wolter G; Hoppe I
    Acta Hepatogastroenterol (Stuttg); 1979 Dec; 26(6):450-6. PubMed ID: 549426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.